SCHEMBL10284773

SCHEMBL10284773

Cc1ccc(S(=O)(=O)Oc2cc(S(=O)(=O)O)cc3c(S(=O)(=O)O)c(N=Nc4c(S(=O)(=O)O)cc5c(S(=O)(=O)O)c(N=Nc6cc(S(=O)(=O)O)c7cc(S(=O)(=O)O)c(N=Nc8ccc([N+](=O)[O-])cc8S(=O)(=O)O)c(O)c7c6N)ccc5c4O)ccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHLPP2 Q6ZVD8 2/20 0.38
▸ ENPP2 Q13822 8/20 0.37
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ ALOX15 P16050 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ CSNK2A1 P68400 1/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ APEX1 P27695 2/20 0.34
▸ NT5E P21589 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10074811 0.99 ENPP2 (0.38) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL6126040 0.99 ENPP2 (0.38) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL6123878 0.93 PHLPP2 (0.33) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL14400964 0.91 CYP1A2 (0.43) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL13852299 0.89 ENPP2 (0.37) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL6123833 0.89 CYP3A4 (0.33) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL14293987 0.87 PHLPP2 (0.43) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL6126063 0.87 ENPP2 (0.45) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL14294346 0.86 ENPP2 (0.43) PHLPP2ENPP2CYP1A2CYP3A4HPGD
SCHEMBL14293793 0.86 HPGD (0.45) PHLPP2ENPP2CYP1A2CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8167991-B2 Trisazo compound, ink composition, recording method, and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-05-01 — — US disclosed
US-20090118479-A1 Azo compound, ink composition, recording method and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-05-07 — — US disclosed
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article JAK1, TMT1A, CDK1 PHLPP2 2764/4885ENPP2 4384/4885CYP1A2 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback